Search Results - "Castaño, Manuel A"

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study by Londoño, María-Carlota, Riveiro-Barciela, Mar, Ahumada, Adriana, Muñoz-Gómez, Raquel, Roget, Mercé, Devesa-Medina, María J, Serra, Miguel Ángel, Navascués, Carmen A, Baliellas, Carme, Aldamiz-Echevarría, Teresa, Gutiérrez, María L, Polo-Lorduy, Benjamín, Carmona, Isabel, Benlloch, Salvador, Bonet, Lucía, García-Samaniego, Javier, Jiménez-Pérez, Miguel, Morán-Sánchez, Senador, Castro, Ángeles, Delgado, Manuel, Gea-Rodríguez, Francisco, Martín-Granizo, Ignacio, Montes, María Luisa, Morano, Luís, Castaño, Manuel A, de Los Santos, Ignacio, Laguno, Montserrat, Losa, Juan Emilio, Montero-Alonso, Marta, Rivero, Antonio, de Álvaro, Cristina, Manzanares, Amanda, Mallolas, Josep, Barril, Guillermina, González-Parra, Emilio, García-Buey, Luisa

“…Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for HCV-infected patients with…”
Get full text

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens by López-Cortés, Luis F, Castaño, Manuel A, López-Ruz, Miguel A, Rios-Villegas, María J, Hernández-Quero, José, Merino, Dolores, Jiménez-Aguilar, Patricia, Marquez-Solero, Manuel, Terrón-Pernía, Alberto, Tellez-Pérez, Francisco, Viciana, Pompeyo, Orihuela-Cañadas, Francisco, Palacios-Baena, Zaira, Vinuesa-Garcia, David, Fajardo-Pico, Jose M, Romero-Palacios, Alberto, Ojeda-Burgos, Guillermo, Pasquau-Liaño, Juan

“…Significant controversy still exists about ritonavir-boosted protease inhibitor monotherapy (mtPI/rtv) as a simplification strategy that is used up to now to…”
Get full text

Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis by Macías, Juan, Orihuela, Francisco, Rivero, Antonio, Viciana, Pompeyo, Márquez, Manuel, Portilla, Joaquín, Ríos, María J., Muñoz, Leopoldo, Pasquau, Juan, Castaño, Manuel A., Abdel-Kader, Laila, Pineda, Juan A.

“…Objectives The aim of this study was to evaluate the incidence and risk factors of severe liver events among HIV-infected patients treated with drug…”
Get full text

Renal safety of coformulated tenofovir/emtricitabine vs other nucleoside analogues in combination therapy in antiretroviral-naive patients aged 50 years or older in Spain: The TRIP study by Pedrol, Enric, Caro-Murillo, Ana M, Castaño, Manuel A, Riera, Melchor, Olalla, Julián, Domingo, Pere, Arazo, Piedad, Gómez-Sirvent, Juan L, Pulido, Federico, Romero-Palacios, Alberto, Aguirrebengoa, Koldo, Vera, Francisco, Ferrer, Pedro, Blanco Ramos, José R

“…Our aim is to describe the impact of emtricitabine (FTC)/tenofovir (TDF) versus other nucleoside reverse transcriptase inhibitor (NRTIs)-based regimens on…”
Get more information

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease by Londoño, María-Carlota, Riveiro-Barciela, Mar, Ahumada, Adriana, Muñoz-Gómez, Raquel, Roget, Mercé, Devesa-Medina, María J, Serra, Miguel Ángel, Navascués, Carmen A, Baliellas, Carme, Aldamiz-Echevarría, Teresa, Gutiérrez, María L, Polo-Lorduy, Benjamín, Carmona, Isabel, Benlloch, Salvador, Bonet, Lucía, García-Samaniego, Javier, Jiménez-Pérez, Miguel, Morán-Sánchez, Senador, Castro, Ángeles, Delgado, Manuel, Gea-Rodríguez, Francisco, Martín-Granizo, Ignacio, Montes, María Luisa, Morano, Luís, Castaño, Manuel A, de los Santos, Ignacio, Laguno, Montserrat, Losa, Juan Emilio, Montero-Alonso, Marta, Rivero, Antonio, de Álvaro, Cristina, Manzanares, Amanda, Mallolas, Josep, Barril, Guillermina, González-Parra, Emilio, García-Buey, Luisa

“…Background and aims Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for…”
Get full text

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens: e0148924 by Lopez-Cortes, Luis F, Castano, Manuel A, Lopez-Ruz, Miguel A, Rios-Villegas, Maria J, Hernandez-Quero, Jose, Merino, Dolores, Jimenez-Aguilar, Patricia, Marquez-Solero, Manuel, Terron-Pernia, Alberto, Tellez-Perez, Francisco

“…Background and Objective Significant controversy still exists about ritonavir-boosted protease inhibitor monotherapy (mtPI/rtv) as a simplification strategy…”
Get full text